| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 21.12.2015 og
angivet som gældende fra 15.12.2015 (3232
dage). |
Ingen historik.
| Branche | | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
| Sidst opdateret den 05.01.2016 og
angivet som gældende fra 15.12.2015 (3232
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 21.12.2015 og
angivet som gældende fra 15.12.2015 (3232
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Eurofins Genomics Denmark A/S. |
| Sidst opdateret den 07.01.2019 og
angivet som gældende fra 03.01.2019 (2117
dage). |
| Historik | Start | Stop |
|---|
| Eurofins Genomics Denmark A/S | 03.01.2019 | |
| Eurofins Genomics A/S | 15.12.2015 | 02.01.2019 |
| Binavne | | Eurofins Genomics A/S. |
| Sidst opdateret den 07.01.2019 og
angivet som gældende fra 07.01.2019 (2113
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden i forening med direktøren eller et bestyrelsesmedlem. |
| Sidst opdateret den 03.06.2016 og
angivet som gældende fra 03.06.2016 (3061
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | bestyrelsen |
| formanden + direktøren |
| formanden + 1 bestyrelsesmedlem |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden i forening med direktøren eller et bestyrelsesmedlem | 03.06.2016 | |
| Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller af den samlede bestyrelse | 15.12.2015 | 02.06.2016 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Deloitte Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33963556
Beskrivelse af revisor:Statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):We conducted our audit in accordance with In-ternational Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Audi-tor’s responsibilities for the audit of the financial statements" section of this auditor’s report. We are independent of the Entity in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these re-quirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opin-ion.
Konklusion (revision):We have audited the financial statements of Eu-rofins Genomics Denmark A/S for the financial year 01. 01. 2023 - 31. 12. 2023, which comprise the income statement, balance sheet, statement of changes in equity, and notes, including a sum-mary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Entity’s financial position at 31. 12. 2023 and of the results of its operations for the financial year 01. 01. 2023 - 31. 12. 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the management commentary and, in doing so, con-sider whether the management commentary is materially inconsistent with the financial state-ments or our knowledge obtained in the audit or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Fi-nancial Statements Act. Based on the work we have performed, we con-clude that the management commentary is in accordance with the financial statements and has been prepared in accordance with the require-ments of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration